{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:26:42Z","timestamp":1787153202034,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.gassur.2026.102490","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:59:11Z","timestamp":1781798351000},"page":"102490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatic arterial infusion chemotherapy review"],"prefix":"10.1016","volume":"30","author":[{"given":"Xavier L.","family":"Baldwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"D\u2019Angelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gassur.2026.102490_bib1","first-page":"107","article-title":"Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo","volume":"12","author":"Bierman","year":"1951","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.gassur.2026.102490_bib2","first-page":"969","article-title":"The blood supply of neoplasms in the liver","volume":"30","author":"Breedis","year":"1954","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.gassur.2026.102490_bib3","first-page":"359","article-title":"Hepatic artery ligation and tumor necrosis in the liver","volume":"59","author":"Mori","year":"1966","journal-title":"Surgery"},{"issue":"7665","key":"10.1016\/j.gassur.2026.102490_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0140-6736(70)92533-X","article-title":"Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs","volume":"2","author":"Murray-Lyon","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.gassur.2026.102490_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM196402132700701","article-title":"Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion","volume":"270","author":"Sullivan","year":"1964","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gassur.2026.102490_bib6","first-page":"176","article-title":"Clinical pharmacology of hepatic arterial chemotherapy","volume":"10","author":"Ensminger","year":"1983","journal-title":"Semin Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2026.102490_bib7","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1200\/JCO.1987.5.11.1836","article-title":"Tumor and liver drug uptake following hepatic artery and portal vein infusion","volume":"5","author":"Sigurdson","year":"1987","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2026.102490_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/sonc.2002.31679","article-title":"Intrahepatic arterial infusion of chemotherapy: pharmacologic principles","volume":"29","author":"Ensminger","year":"2002","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102490_bib9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/1097-0142(19800301)45:5<866::AID-CNCR2820450507>3.0.CO;2-3","article-title":"Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump","volume":"45","author":"Buchwald","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2026.102490_bib10","series-title":"Intera 3000 hepatic artery infusion (HAI) pump [Internet]","author":"Intera Oncology","year":"2025"},{"issue":"5","key":"10.1016\/j.gassur.2026.102490_bib11","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1245\/s10434-025-16915-8","article-title":"Robotic versus open placement of hepatic artery infusion pumps","volume":"32","author":"Schleimer","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2026.102490_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/BF02557524","article-title":"The management of variant arterial anatomy during hepatic arterial infusion pump placement","volume":"9","author":"Allen","year":"2002","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102490_bib13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/SLA.0000000000005434","article-title":"Hepatic artery infusion pumps: a surgical toolkit for intraoperative decision-making and management of hepatic artery infusion-specific complications","volume":"276","author":"Sharib","year":"2022","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.gassur.2026.102490_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jso.25913","article-title":"Hepatic artery infusion pumps","volume":"122","author":"Thiels","year":"2020","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2026.102490_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jso.24325","article-title":"Robotic assisted placement of hepatic artery infusion pump is a safe and feasible approach","volume":"114","author":"Dhir","year":"2016","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102490_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.hpb.2016.12.015","article-title":"Robotic hepatic arterial infusion pump placement","volume":"19","author":"Qadan","year":"2017","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.gassur.2026.102490_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1200\/JCO.1985.3.1.98","article-title":"Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine","volume":"3","author":"Hohn","year":"1985","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2026.102490_bib18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00000658-198508000-00007","article-title":"Sclerosing cholangitis after continuous hepatic artery infusion of FUDR","volume":"202","author":"Kemeny","year":"1985","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.gassur.2026.102490_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/1097-0142(19920115)69:2<327::AID-CNCR2820690209>3.0.CO;2-U","article-title":"A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer","volume":"69","author":"Kemeny","year":"1992","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.gassur.2026.102490_bib20","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1245\/s10434-011-2102-8","article-title":"Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors","volume":"19","author":"Ito","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102490_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2005.03.019","article-title":"Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases","volume":"201","author":"Allen","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"5","key":"10.1016\/j.gassur.2026.102490_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.1983.1.5.337","article-title":"Long-term hepatic arterial infusion of 5-Fluorodeoxyuridine for liver metastases using an implantable infusion pump","volume":"1","author":"Weiss","year":"1983","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2026.102490_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7326\/0003-4819-107-4-459","article-title":"Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial","volume":"107","author":"Kemeny","year":"1987","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.gassur.2026.102490_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198712000-00001","article-title":"A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases","volume":"206","author":"Chang","year":"1987","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.gassur.2026.102490_bib25","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","article-title":"Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)","volume":"24","author":"Kemeny","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2026.102490_bib26","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1989.7.11.1646","article-title":"A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial","volume":"7","author":"Hohn","year":"1989","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2026.102490_bib27","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archsurg.1990.01410200086013","article-title":"Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial","volume":"125","author":"Martin","year":"1990","journal-title":"Arch Surg"},{"issue":"7","key":"10.1016\/j.gassur.2026.102490_bib28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","article-title":"Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial","volume":"10","author":"Rougier","year":"1992","journal-title":"J Clin Oncol"},{"issue":"8932","key":"10.1016\/j.gassur.2026.102490_bib29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(94)90750-1","article-title":"Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases","volume":"344","author":"Allen-Mersh","year":"1994","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.gassur.2026.102490_bib30","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1200\/JCO.2008.20.1301","article-title":"Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma","volume":"27","author":"Kemeny","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2026.102490_bib31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jso.24898","article-title":"Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: long term results and curative potential","volume":"117","author":"Pak","year":"2018","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102490_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1245\/s10434-016-5418-6","article-title":"Hepatic arterial infusion in combination with modern systemic chemotherapy is associated with improved survival compared with modern systemic chemotherapy alone in patients with isolated unresectable colorectal liver metastases: a case-control study","volume":"24","author":"Dhir","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"21","key":"10.1016\/j.gassur.2026.102490_bib33","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2013.53.2473","volume":"32","author":"Schwartzberg","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102490_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jso.24399","article-title":"Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies","volume":"114","author":"Cercek","year":"2016","journal-title":"J Surg Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2026.102490_bib35","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1007\/s00423-022-02707-1","article-title":"Cohort study of long-term survival and recurrence patterns following operative management of colorectal liver metastasis - is follow-up beyond 5 years warranted?","volume":"407","author":"Hajibandeh","year":"2022","journal-title":"Lange Arch Surg"},{"issue":"12","key":"10.1016\/j.gassur.2026.102490_bib36","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2026.102490_bib37","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/ans.17835","article-title":"Recurrence patterns predict survival after resection of colorectal liver metastases","volume":"92","author":"Wong","year":"2022","journal-title":"ANZ J Surg"},{"issue":"27","key":"10.1016\/j.gassur.2026.102490_bib38","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","article-title":"Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer","volume":"341","author":"Kemeny","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gassur.2026.102490_bib39","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00000658-199812000-00006","article-title":"Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German cooperative on liver metastases (Arbeitsgruppe Lebermetastasen)","volume":"228","author":"Lorenz","year":"1998","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.gassur.2026.102490_bib40","first-page":"1499","article-title":"Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study","volume":"20","author":"Kemeny","year":"2002","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.gassur.2026.102490_bib41","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.ejso.2021.07.024","article-title":"Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: a systematic review and meta-analysis","volume":"47","author":"Bosma","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"17","key":"10.1016\/j.gassur.2026.102490_bib42","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1200\/JCO.2016.71.8346","article-title":"Perioperative hepatic arterial infusion pump chemotherapy is associated with longer survival after resection of colorectal liver metastases: a propensity score analysis","volume":"35","author":"Koerkamp","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2026.102490_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jso.24189","article-title":"Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy","volume":"113","author":"Kemeny","year":"2016","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102490_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SLA.0b013e31827b9005","article-title":"Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy","volume":"257","author":"Go\u00e9r\u00e9","year":"2013","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.gassur.2026.102490_bib45","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/SLA.0000000000003248","article-title":"Adjuvant hepatic artery infusion chemotherapy is associated with improved survival regardless of KRAS mutation status in patients with resected colorectal liver metastases: a retrospective analysis of 674 patients","volume":"272","author":"Gholami","year":"2020","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.gassur.2026.102490_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.hpb.2021.10.014","article-title":"Adjuvant intra-arterial chemotherapy for patients with resected colorectal liver metastases: a systematic review and meta-analysis","volume":"24","author":"Buisman","year":"2022","journal-title":"HPB"},{"issue":"1","key":"10.1016\/j.gassur.2026.102490_bib47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"248","author":"Endo","year":"2008","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.gassur.2026.102490_bib48","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.hpb.2023.06.019","article-title":"Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma","volume":"25","author":"Olthof","year":"2023","journal-title":"HPB"},{"issue":"2","key":"10.1016\/j.gassur.2026.102490_bib49","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1245\/s10434-007-9627-x","article-title":"Surgical management of intrahepatic cholangiocarcinoma--a population-based study","volume":"15","author":"Tan","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2026.102490_bib50","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"issue":"14","key":"10.1016\/j.gassur.2026.102490_bib51","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.gassur.2026.102490_bib52","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/annonc\/mdp029","article-title":"Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival","volume":"20","author":"Jarnagin","year":"2009","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2026.102490_bib53","first-page":"200","article-title":"Advanced intrahepatic cholangiocarcinoma: post hoc analysis of the ABC-01, \u221202, and \u221203 clinical trials","volume":"112","author":"Lamarca","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.gassur.2026.102490_bib54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaoncol.2019.3718","article-title":"Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial","volume":"6","author":"Cercek","year":"2020","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102490_bib55","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00432-024-05795-2","article-title":"First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma","volume":"150","author":"Lin","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2026.102490_bib56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1200\/JCO-25-00923","article-title":"Hepatic arterial infusion pump chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma-PUMP-2 trial","volume":"44","author":"Franssen","year":"2025","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2026.102490_bib57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12885-019-5515-6","article-title":"Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial","volume":"19","author":"Buisman","year":"2019","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.gassur.2026.102490_bib58","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.hpb.2022.08.008","article-title":"Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network","volume":"24","author":"Cavnar","year":"2022","journal-title":"HPB"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X2600171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X2600171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:48:00Z","timestamp":1787150880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X2600171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1091255X2600171X"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2026.102490","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic arterial infusion chemotherapy review","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2026.102490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102490"}}